CSIMarket
 
Omnicell inc   (OMCL)
Other Ticker:  
 
    Sector  Technology    Industry Computer Hardware
   Industry Computer Hardware
   Sector  Technology
 
Price: $27.4700 $-0.22 -0.795%
Day's High: $27.99 Week Perf: -2.17 %
Day's Low: $ 26.85 30 Day Perf: -2.93 %
Volume (M): 668 52 Wk High: $ 77.14
Volume (M$): $ 18,355 52 Wk Avg: $49.80
Open: $27.86 52 Wk Low: $25.69



 Market Capitalization (Millions $) 1,244
 Shares Outstanding (Millions) 45
 Employees 3,800
 Revenues (TTM) (Millions $) 1,147
 Net Income (TTM) (Millions $) -20
 Cash Flow (TTM) (Millions $) 148
 Capital Exp. (TTM) (Millions $) 41

Omnicell Inc
Omnicell, a pioneer in revolutionizing the pharmacy care delivery paradigm, is dedicated to elevating pharmacys position in healthcare and transforming drug management as a critical component of care delivery. We accomplish it by leveraging an industry-leading complete intelligent infrastructure that combines technology, analytics, and professional services to equip and empower pharmacists and pharmacies to focus on clinical care rather than administrative duties. This intelligent infrastructure is key to attaining the industry goal of the Autonomous Pharmacy, which was characterized by pharmacy executives as enhancing operational efficiency and ultimately aiming for zero-error drug administration.
We believe our robust customer base and channel within the pharmacy care market creates a network of insights and understandings that enable us to bring new solutions and innovations to market. Facilities worldwide use our automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. Institutional and retail pharmacies across North America, the United Kingdom, Germany, and Australia leverage our innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. We believe our committed customer base and strategic planning, along with a broad portfolio of products and services, combined with innovation, aligns us with the long-term trends of the healthcare market to manage patients across the continuum of care while helping to control costs and improve patient outcomes.


As we continue to execute on the industry vision of the Autonomous Pharmacy, we are enabling our current offerings to operate on a cloud-based platform in an effort to build out an intelligent medication management infrastructure. We have invested in broadening our solutions across two key areas: automation and advanced services, as explained below.
Automation

Our automation products and technology-enabled services span the evolving continuum of care, including acute, post-acute, ambulatory, and retail pharmacies. We provide a range of advanced automation, including robotics designed to automate work, streamline workflows, and reduce human error. Across these settings, we provide central pharmacy automation solutions for both medication dispensing and IV compounding systems, as well as medication and supply dispensing systems at the point of care. We also provide patient engagement solutions to help improve adherence to prescriptions. With certain automation and technology-enabled service offerings, we provide expert services to optimize utilization through subscription agreements, inclusive of personnel to operate the equipment. Our automation offerings include:
Point of Care

Our point of care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. Automated dispensing systems are an essential part of medication management because they safeguard medications'including controlled substances'and automatically track inventory. We strive to continually innovate our automated dispensing systems to close gaps in safety and enable clinicians to spend less time managing medications and more time caring for patients.
Our XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, we also offer specialized automated dispensing systems. Our interoperability solutions integrate all of our automated dispensing systems with key electronic health record systems to streamline workflow and increase accuracy.
Central Pharmacy

An efficient central pharmacy operation is vital to delivering exceptional patient care. With pharmacist and technician labor requirements increasing and resource shortages escalating over the years, it is critical for pharmacies to find new ways to increase productivity. Our medication management platform offers a broad range of automated hardware and software solutions. Our central pharmacy automation solutions are designed to empower healthcare providers to increase staff efficiency, reduce inventory costs, prevent medication errors, improve compliance, and strengthen security surrounding controlled substances. By automating manual, error-prone processes, we believe our technology and advanced services directly contribute to clinical care by enabling pharmacy staff to work more efficiently.
Our central pharmacy automation solutions include: automated storage and retrieval systems, including our XR2 Automated Central Pharmacy System ' an important building block to the industry vision of the Autonomous Pharmacy; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems.
Medication Adherence

Our medication adherence solutions are used by retail, community, and outpatient pharmacies, as well as by institutional pharmacies serving long-term care and other sites outside the acute care hospital, and are designed to improve pharmacy operations and patient adherence to prescriptions.
Our single-dose automation solutions fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions. Our fully automated and semi-automated filling equipment is designed specifically for institutional pharmacies with enough order volume to warrant automated packaging of medications. Our automated solutions interface with pharmacy information systems to obtain prescription information.
For multi-medication prescriptions, we offer software that guides users through the manual filling process to streamline workflow and increase packaging accuracy. In addition, we also offer a wide range of medication blister card packaging and packaging supplies designed to enhance medication adherence in a variety of non-acute care settings. These products include multimed blister cards (adherence packaging) distributed by retail, community, and outpatient pharmacies to help patients manage their medication regimens at home. These cards organize multiple drugs into a single blister cavity for each dosing time, making it easier for patients on complex regimens to comply with their therapy. For environments where a caregiver is present, institutional and retail pharmacies use our single-dose blister cards, which provide up to 90 daily doses of a specific single medication.
Other Automation Products and Services

Omnicell Interface Software provides interface and integration between our medication-use products or our supply products and healthcare facilities in-house information management systems.
Our Technical Services include customer education, training, and post-installation technical support with phone and web-based support through our U.S.-based technical support centers, on-site service, parts, and access to software upgrades. Product support is available through fixed-period service contracts and on a time-and-materials basis. On-site service is provided by our field service team.
Retail Pharmacy and Hospital Automation Outside the United States

Additional products sold outside the United States include robotic dispensing systems used in hospitals and retail pharmacies for handling the stocking and retrieval of boxed medications. For management of medical supplies, a specialized cabinet that uses radio frequency identification is also available, which is designed to improve the accuracy of inventory management.
Advanced Services

With nearly 30 years of experience delivering automation solutions, Omnicell believes that supporting the industry vision of the Autonomous Pharmacy requires the addition of digital workflows, analytics, and experts to achieve more sophisticated outcomes. Leveraging data through predictive and prescriptive analytics, sourced from operational data generated by thousands of facilities utilizing our solutions, we believe we are able to provide actionable insights to help customers better understand their medication usage and improve pharmacy supply chain management. We offer specialized services and analytics software designed to help healthcare facilities improve their bottom line and patient care by harnessing data from automation and other systems.
Our Omnicell OneTM solution, a technology-enabled service, combines cloud-based predictive analytics with expert services designed to drive enterprise improvements in medication inventory optimization, medication waste reduction, and drug diversion monitoring.
Our Central Pharmacy IV Compounding Service offers a comprehensive service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs that is intended to reduce medication costs while improving safety and supply chain dependability. Our Central Pharmacy Dispensing Service, inclusive of the XR2 automated central pharmacy system, is a full-service central pharmacy automation solution designed to improve inventory control, compliance, safety, and efficiency through automation, supported by operational staff, maintenance, and optimization services.
Our 340B solution provides a combination of software, deep knowledge of the 340B program, and technology-enabled services, to help deliver superior outcomes in both savings and compliance, optimizing the 340B program for eligible entities. The suite of offerings includes split billing software, contract pharmacy administration, specialty contract pharmacy administration, and drug discount access solutions.
The newly acquired ReCept solution is focused on specialty pharmacy management services, including specialty pharmacy expertise and operational capabilities, human resources, technology and integration, workflow management, payor access assistance, and other aspects of managing a specialty pharmacy. This total solution for provider groups, federally qualified health centers, and health systems supports on-site management of specialty pharmacy services, including payor contracting, staffing, licensing, quality assurance, 340B administration, and preferred pricing agreements designed to improve margin and profitability, while keeping the patient at the center of care.
EnlivenHealth offers a portfolio of patient engagement and medication management tools designed to help improve health outcomes. EnlivenHealth Patient Engagement is a web-based nexus of solutions designed to comprehensively support improvement in health outcomes related to medication use. EnlivenHealth Patient Engagement includes clinical solutions such as CareScheduler, Medication Synchronization, Immunization and Scheduling, Targeted Patient Interventions, Medication Therapy Management, Opioid Mitigation Solution, and an Omnichannel communications platform, which enables tailoring of patient contact to individual preferences. Additionally, we believe our recent acquisition of MarkeTouch Media's mobile and web-based technology and patient engagement solutions will strengthen the EnlivenHealth suite of industry-leading software-as-a-service ('SaaS') based solutions. Combined with advanced analytics to stratify populations and prioritize patient interventions, we believe these solutions support improved performance for both pharmacies and health plans, helping them to succeed in value-based healthcare by driving health outcomes - better care, better health, and lower costs.


   Company Address: 4220 North Freeway Fort Worth 76137 TX
   Company Phone Number: 415-9990   Stock Exchange / Ticker: NASDAQ OMCL
   


Customers Net Income fell by OMCL's Customers Net Profit Margin fell to

-11 %

2.18 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
MCK   -0.29%    
UNH   -0.47%    
• View Complete Report
   



Omnicell Inc

Headline: Omnicell Inc Faces Financial Turmoil with Revenue Plummeting in Q4 2023

Omnicell Inc, a leading provider of automation and business analytics solutions for the healthcare industry, has had a rough financial interval ending December 31, 2023. The company reported a loss of $-0.32 per share, compared to a loss of $-0.64 per share in the previous year. This decline in earnings per share is concerning and indicates a lack of profitability.
Furthermore, the revenue for Omnicell Inc plummeted by a significant -12.722% to $259.80 million from $297.67 million in the comparable reporting season a year before. This substantial decrease in revenue highlights a major setback for the company and suggests a decline in demand for its products and services. Sequentially, the revenue deteriorated even further by -12.807% from $297.96 million, indicating a worsening trend.

Omnicell Inc

OMCLs Examine Soft Revenue during Third Quarter of 2023, Revealing Potential Challenges for Omnicell Inc.

The stock market can be a volatile and unpredictable place, but despite that, there are always opportunities for investors to find success. Amidst the fluctuations, there are companies that manage to navigate through challenging times and emerge stronger than before. One such company is Omnicell Inc, a leader in the Computer Hardware industry.
For the fiscal third quarter of 2023, Omnicell Inc faced a decline in net profit per share by -67.57% to $0.12 per share, compared to $0.37 in the previous year. However, it is important to note that the company's EPS soared by an impressive 50% from $0.08 per share in the previous financial reporting period. Though this may seem contradictory at first glance, it indicates the potential for growth and resilience in the company's performance.

Omnicell Inc

Omnicell Inc Experiences Staggering 9.941% Revenue Drop in Q2 2023: A Tectonic Shift in Earnings Landscape!

During the past 5 trading days, Omnicell Inc shares have seen a positive trend, improving by 1.21%. This brings the year-to-date performance of the company to an impressive 22.16%. Furthermore, the company's shares are currently trading 36.5% above its 52-week low.
However, despite these positive figures, Omnicell Inc's recent financial report for the period ending June 30, 2023, reflects a significant decline in its earnings per share (EPS). The EPS plummeted by -60% to $0.08 per share, mainly due to a decrease in revenue of -9.941% to $298.44 million when compared to the same period last year. In contrast, the Computer Hardware company reported revenue of $290.63 million and a bottom line of $-0.33 per share in the previous financial reporting period.

Omnicell Inc

Omnicell Inc. Faces Increasing Shortfall as Business Declines in Q1 2023

Omnicell, Inc. is a healthcare technology company that offers automation and workflow management solutions for healthcare facilities. Unfortunately, the first quarter of 2023 earnings season has not been kind to Omnicell. Lower orders have led to diminishing revenues and a greater deficit for the company.
According to the earnings report released recently, Omnicell has suffered a loss of $0.33 per share for the first quarter of 2023. This represents a significant drop from the previous reporting period, when the company reported a bottom line of $0.64 per share. In addition, the company's revenue for the quarter fell by 8.845% compared to the same period last year. The revenue figure for the first quarter of 2023 was $290.63 million, while in the previous year, it was $297.67 million.






 

Omnicell Inc's Segments
 
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Omnicell Inc does not provide revenue guidance.

Earnings Outlook
Omnicell inc does not provide earnings estimates.

 
Geographic Revenue Dispersion




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com